Population Pharmacokinetics of Losmapimod in Healthy Subjects and Patients with Rheumatoid Arthritis and Chronic Obstructive Pulmonary Diseases

被引:0
|
作者
Shuying Yang
Pauline Lukey
Misba Beerahee
Frank Hoke
机构
[1] Quantitative Sciences,Clinical Pharmacology Modelling and Simulation
[2] GlaxoSmithKline,Clinical Pharmacology Modelling and Simulation
[3] Fibrosis Discovery Performance Unit,Clinical Pharmacology Modelling and Simulation
[4] GlaxoSmithKline,undefined
[5] Quantitative Sciences,undefined
[6] GlaxoSmithKline,undefined
[7] Quantitative Sciences,undefined
[8] GlaxoSmithKline,undefined
来源
Clinical Pharmacokinetics | 2013年 / 52卷
关键词
Rheumatoid Arthritis; Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Prediction Interval; Population Pharmacokinetic Model;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:187 / 198
页数:11
相关论文
共 50 条
  • [21] Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study
    Shen, T-C
    Lin, C-L
    Chen, C-H
    Tu, C-Y
    Hsia, T-C
    Shih, C-M
    Hsu, W-H
    Sung, F-C
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2014, 107 (07) : 537 - 543
  • [22] A comparison of muscle dysfunction in patients with chronic obstructive pulmonary disease and healthy subjects
    Djebaili, Rachida
    Heddane, Radia
    Direche, Rania
    Oulmi, Mounira
    Djebbar, Abelmadjid
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [23] Food Pyramid for Subjects with Chronic Obstructive Pulmonary Diseases
    Rondanelli, Mariangela
    Faliva, Milena Anna
    Peroni, Gabriella
    Infantino, Vittoria
    Gasparri, Clara
    Iannello, Giancarlo
    Perna, Simone
    Alalwan, Tariq AbdulKarim
    Al-Thawadi, Salwa
    Corsico, Angelo Guido
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 1435 - 1448
  • [24] Population Pharmacokinetics of Eltrombopag in Healthy Subjects and Patients With Chronic Idiopathic Thrombocytopenic Purpura
    Gibiansky, Ekaterina
    Zhang, Jianping
    Williams, Daphne
    Wang, Zhao
    Ouellet, Daniele
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (06): : 842 - 856
  • [25] Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures
    Bockbrader, Howard N.
    Burger, Paula
    Knapp, Lloyd
    Corrigan, Brian W.
    EPILEPSIA, 2011, 52 (02) : 248 - 257
  • [26] Population Pharmacokinetics of CMAB008 (an Infliximab Biosimilar) and Remicade® in Healthy Subjects and Patients with Moderately to Severely Active Rheumatoid Arthritis
    Su, Yin
    Li, Jing
    Wang, Chenguang
    Zhang, Xunmin
    Hou, Sheng
    Guo, Huaizu
    Deng, Chenhui
    Ou, Lun
    Wang, Jinwei
    ADVANCES IN THERAPY, 2023, 40 (03) : 1005 - 1018
  • [27] Population Pharmacokinetics of CMAB008 (an Infliximab Biosimilar) and Remicade® in Healthy Subjects and Patients with Moderately to Severely Active Rheumatoid Arthritis
    Yin Su
    Jing Li
    Chenguang Wang
    Xunmin Zhang
    Sheng Hou
    Huaizu Guo
    Chenhui Deng
    Lun Ou
    Jinwei Wang
    Advances in Therapy, 2023, 40 : 1005 - 1018
  • [28] Population Pharmacokinetics of Inhaled Umeclidinium and Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
    Goyal, Navin
    Beerahee, Misba
    Kalberg, Chris
    Church, Alison
    Kilbride, Sally
    Mehta, Rashmi
    CLINICAL PHARMACOKINETICS, 2014, 53 (07) : 637 - 648
  • [29] Population Pharmacokinetics of Inhaled Umeclidinium and Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
    Navin Goyal
    Misba Beerahee
    Chris Kalberg
    Alison Church
    Sally Kilbride
    Rashmi Mehta
    Clinical Pharmacokinetics, 2014, 53 : 637 - 648
  • [30] Risk of Chronic Obstructive Pulmonary Disease (COPD) in Rheumatoid Arthritis (RA): A Population Based Study
    McGuire, Katherine
    Avina-Zubieta, Antonio
    Sayre, Eric
    Abrahamowicz, Michal
    Esdaile, John
    Lacaille, Diane
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1181 - 1181